Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Infosys Limited
  6. News
  7. Summary
    INFY   INE009A01021


Delayed Quote. Delayed NSE India Stock Exchange - 06/14 07:14:08 am
1461.8 INR   +1.03%
07:25aIndian Stocks Open the Week in the Green
06:39aIndian shares end higher as Reliance gains; inflation data in focus
06:30aIndian shares end higher as Reliance gains; inflation data in focus
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Infosys : Drug Discovery Informatics Market Technology 2021 Statistical Analysis, Key Segments, Benefits, Opportunity and Forecast 2027 by Top Players Accenture, IBM, Cognizant, Infosys Limited and etc

05/07/2021 | 04:19am EDT

Drug Discovery Informatics Market To Reach USD 4.09 Billion By 2027

Rising prevalence of chronic diseases and increasing investment in research & development are key factors driving growth of the drug discovery informatics market.

Drug Discovery Informatics Market Size - USD 2.02 Billion in 2019, Growth - CAGR of 9.2%, Trends - Advancement in technology.

The global drug discovery informatics market is expected to reach a market size of USD 4.09 Billion by 2027 and register a high CAGR during the forecast period, according to latest analysis by Reports and Data.

Growth of the drug discovery informatics market is driven by rising need to analyze large volumes of data, increasing use of Information Technology in data mining and data analysis with regard to drug development, data visualization, progressions in software versions for data aggregation, and increased usage of cloud-based services.

Emergence of cloud-based technologies and innovative analytics are among other factors driving growth of the drug discovery informatics market. Cloud enables storage, processing, and analyzing large volume of dataset at low cost. Adoption of new computer and infrastructure technologies results in faster and better scientific research. Cloud has the potential to increase the speed of basic research projects.

The increasing shift from conventional to data-driven technologies by pharmaceutical companies is another key factor expected to propel growth of the drug discovery informatics market. However, high cost of drug discovery informatics can limit its adoption in various sectors.

Key participants include Accenture, Clarivate Analytics, Infosys Limited, Eurofins Scientific, IBM, Cognizant, Thermo Fisher Scientific, Jubilant Life Sciences, PerkinElmer, and Dassault Systemes.

Click Here To Access The Sample Report: https://www.reportsanddata.com/sample-enquiry-form/3767

The COVID-19 impact:

The COVID-19 pandemic has spurred growth of drug discovery informatics market. Biopharmaceutical companies are investing significantly in research for development of SARS-COV-2 vaccine. Researchers are identifying drugs for treatment of the disease by examining both new and existing drugs, which is driving growth of the drug discovery informatics market.

Further key findings in the report*Molecular modeling is an essential tool for drug design process and is used in computational biology, material science, and computational chemistry. Revenue growth of this segment is driven by rise in demand in research of chronic diseases such as cancer, arthritis, and HIV-AIDS.

*Pharmaceutical industries segment dominated other end-use segments in terms of revenue share in 2019. Companies are using drug discovery informatics software for target identification, pre-clinical research & development, which is fueling growth of the drug discovery informatics market.

*Exploration of advanced software has emerged a key component in drug discovery for the expansion of bio-active drugs across various therapeutic areas. Proper usage of software resolves several challenges in drug discovery.

*North America accounted for the largest revenue share in the drug discovery informatics market in 2019. Robust presence of advanced research infrastructures in countries in the region and rising adoption of advanced technological devices is another factor supporting market growth.

Quick buy @ https://www.reportsanddata.com/checkout-form/3767

For the purpose of this report, Reports and Data has segmented the global drug discovery informatics market on the basis of function, solution, application, end-use, and region:

Function Outlook (Revenue, USD Billion; 2017-2027)*Docking *Sequencing & target data analysis *Library & database preparation *Molecular modeling *Other

Solution Outlook (Revenue, USD Billion; 2017-2027)*Software *Services

Application Outlook (Revenue, USD Billion; 2017-2027)*Drug Development*Preclinical Testing *Clinical Trials*Drug Discovery

End-use Outlook (Revenue, USD Billion; 2017-2027)*Biotechnology *Pharmaceutical *Contract research organizations

Regional Outlook (Revenue, USD Billion; 2017-2027)*North America*U.S *Canada*Europe*Germany *U.K *France *BENELUX *Rest of Europe*Asia Pacific*China *Japan *South Korea *Rest of APAC*MEA*Saudi Arabia *UAE *Rest of MEA*Latin America*Brazil *Rest of LATAM

Ask for discount @ https://www.reportsanddata.com/discount-enquiry-form/3767

Table of Content:

Chapter 1. Market Synopsis

1.1. Market Definition

1.2. Research Scope & Premise

1.3. Methodology

1.4. Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2019-2027

Chapter 3. Indicative Metrics

Chapter 4. Drug Discovery Informatics Market Segmentation & Impact Analysis

4.1. Drug Discovery Informatics Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Market indicators analysis

4.2.2. Market drivers analysis


Chapter 10. Competitive Landscape

10.1. Market Revenue Share By Manufacturers

10.2. Manufacturing Cost Breakdown Analysis

10.3. Mergers & Acquisitions

10.4. Market positioning

10.5. Strategy Benchmarking

10.6. Vendor Landscape

Chapter 11. Company Profiles

11.1. Accenture

11.1.1. Company Overview

11.1.2. Financial Performance

11.1.3. Technology Insights

11.1.4. Strategic Initiatives

11.2. Clarivate Analytics

11.2.1. Company Overview

11.2.2. Financial Performance

11.2.3. Technology Insights

11.2.4. Strategic Initiatives


Speak to Our Expert @ https://www.reportsanddata.com/speak-to-analyst-form/3767

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Media Contact

Company Name: Reports and Data

Contact Person: John Watson

Email: sales@reportsanddata.com

Phone: +1-212-710-1370

Address:40 Wall St. 28th floor

City: New York City

State: NY 10005

Country: United States

Website: https://www.reportsanddata.com/report-detail/drug-discovery-informatics-market

Source: www.abnewswire.com


(C) 2021 M2 COMMUNICATIONS, source M2 PressWIRE

Stocks mentioned in the article
ChangeLast1st jan.
INFOSYS LIMITED 1.03% 1461.8 Delayed Quote.15.22%
All news about INFOSYS LIMITED
07:25aIndian Stocks Open the Week in the Green
06:39aIndian shares end higher as Reliance gains; inflation data in focus
06:30aIndian shares end higher as Reliance gains; inflation data in focus
06/11Indian shares close at record high as COVID-19 curbs ease
06/10Paytm, MakeMyTrip, Infosys offer to help India with COVID vaccine bookings
06/10Financials boost Indian shares; U.S. inflation data eyed
06/09INFOSYSá : Honored with Stevie« Awards at the 2021 American Business Awards
06/08Indian shares end slightly lower as global inflation worries weigh
06/08Infosys to Help Enhance Archrock's Field Services, Operations
06/08Indian shares erase gains as global inflation worries weigh
More news
Sales 2022 1 168 B 15 957 M 15 957 M
Net income 2022 223 B 3 044 M 3 044 M
Net cash 2022 325 B 4 443 M 4 443 M
P/E ratio 2022 27,4x
Yield 2022 2,10%
Capitalization 6 206 B 84 752 M 84 761 M
EV / Sales 2022 5,03x
EV / Sales 2023 4,45x
Nbr of Employees 259 619
Free-Float 84,9%
Duration : Period :
Infosys Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INFOSYS LIMITED
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 37
Average target price 1 595,36 INR
Last Close Price 1 461,80 INR
Spread / Highest target 45,3%
Spread / Average Target 9,14%
Spread / Lowest Target -42,5%
EPS Revisions
Managers and Directors
Salil S. Parekh Chief Executive Officer, MD & Executive Director
Mohit Joshi Co-President
Ravi Kumar S. Co-President & Deputy Chief Operating Officer
Nilanjan Roy Chief Financial Officer
Nandan M. Nilekani Non-Executive Chairman
Sector and Competitors
1st jan.Capitalization (M$)
ACCENTURE PLC9.21%181 337
SNOWFLAKE INC.-14.50%71 248